Reimagining the landscape of therapeutic innovation, pharmaceutical biotechnology & drug discovery leverages molecular biology, genomics, and cell culture systems to create next-generation biopharmaceuticals. Monoclonal antibodies, recombinant proteins, and RNA-based therapies are now pivotal in treating complex diseases, including cancer and autoimmune disorders. High-throughput screening, structure-based drug design, and bioinformatics platforms expedite the identification of potent drug candidates. In Pharmaceutical Biotechnology & Drug Discovery, personalized medicine is also gaining traction through biomarkers and companion diagnostics, enabling tailored treatments. Furthermore, biotechnology enhances drug delivery via nanocarriers and controlled-release systems, improving efficacy and patient compliance. This evolving field plays a central role in shaping modern healthcare, offering precision, safety, and scalability in therapeutic development.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain